Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 64 (TRIM64) is a member of the TRIM family characterized by the RBCC motif, which consists of a RING finger, one or two B-box zinc fingers, and a coiled-coil domain[1][3][5]. Most TRIM proteins act as E3 ubiquitin ligases, regulating protein stability and cellular signaling. TRIM64 is predicted to have ubiquitin-ligase activity and may play roles in the innate immune response by analogy to its family members, although its detailed function is not well-characterized. TRIM family proteins in general are important for pathogen-resistance, innate immunity, and regulation of transcriptional pathways in host defense[1][3][5]. There is currently no strong evidence for TRIM64 as a therapeutic target or a widely used disease biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 64 (TRIM64).